Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Senores Pharmaceuticals Limited (NSE: SENORES), ISIN INE0RB801010 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SENORES last traded at ₹1175.15 (+1.22%), with a 52-week range of ₹706.00 to ₹1599.00 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 45.82%, FIIs 6.01%, DIIs 10.85%, mutual funds 7.36%.
EquiSense Score (ECS): 75/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.